Teen-Adult Atopic Dermatitis Research Trial (61 Weeks)

Teens and adults aged 12 to 75 years old with a diagnosis of atopic dermatitis (AD) for at least 1 year, may qualify to participate. Individuals must have moderate to severe AD with involvement of 10% or more body surface area (BSA). A body weight of 40 kg/88 lbs or more is required at the time of screening. Recent history (within 6 months) of inadequate response or inability to tolerate topical AD treatments (topical corticosteroids or topical calcineurin inhibitors) or who have required systemic treatments for control of their disease, is also needed.

Participants will receive investigational oral medication (active study drug) or placebo, during the initial treatment phase. In the extension treatment phase, those who previously received placebo will be assigned to receive active study drug. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 61 weeks and involve about 12 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more